Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira M Jacobson

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Gastroenterology & Hepatology|February 28, 2024
Reflecting on a Decade of Sofosbuvir Use for Hepatitis C Virus TreatmentIra M Jacobson
Gastroenterology|September 12, 2018
Does Ribavirin Still Have a Role in Sofosbuvir and Velpatasvir Therapy for Patients With HCV Genotype 3 Infection and Cirrhosis?Ira M Jacobson
Journal of Hepatology|March 12, 2008
Combination therapy for chronic hepatitis B: ready for prime time?Ira M Jacobson
Gastroenterology & Hepatology|November 25, 2010
Emerging and novel therapies for hepatitis CIra M Jacobson
The American Journal of Gastroenterology|February 2, 2006
Therapeutic options for chronic hepatitis B: considerations and controversiesIra M Jacobson
Gastroenterology & Hepatology|January 11, 2017
The HCV Treatment Revolution Continues: Resistance Considerations, Pangenotypic Efficacy, and Advances in Challenging PopulationsIra M Jacobson
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2009
Treatment options for patients with chronic hepatitis C not responding to initial antiviral therapyIra M Jacobson
Clinical Liver Disease|May 2, 2019
The extinction of chronic viral hepatitis?Sonal Kumar, Ira M Jacobson
Expert Review of Gastroenterology & Hepatology|July 5, 2017
Sofosbuvir, velpatasvir and voxilaprevir combination for the treatment of hepatitis CRebecca Voaklander, Ira M Jacobson
Journal of the American Academy of Nurse Practitioners|July 28, 2011
Role of the nurse practitioner in the management of patients with chronic hepatitis CMary Olson, Ira M Jacobson
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Gastroenterology & Hepatology|February 28, 2024
Reflecting on a Decade of Sofosbuvir Use for Hepatitis C Virus TreatmentIra M Jacobson
Gastroenterology|September 12, 2018
Does Ribavirin Still Have a Role in Sofosbuvir and Velpatasvir Therapy for Patients With HCV Genotype 3 Infection and Cirrhosis?Ira M Jacobson
Journal of Hepatology|March 12, 2008
Combination therapy for chronic hepatitis B: ready for prime time?Ira M Jacobson
Gastroenterology & Hepatology|November 25, 2010
Emerging and novel therapies for hepatitis CIra M Jacobson
The American Journal of Gastroenterology|February 2, 2006
Therapeutic options for chronic hepatitis B: considerations and controversiesIra M Jacobson
Gastroenterology & Hepatology|January 11, 2017
The HCV Treatment Revolution Continues: Resistance Considerations, Pangenotypic Efficacy, and Advances in Challenging PopulationsIra M Jacobson
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2009
Treatment options for patients with chronic hepatitis C not responding to initial antiviral therapyIra M Jacobson
Clinical Liver Disease|May 2, 2019
The extinction of chronic viral hepatitis?Sonal Kumar, Ira M Jacobson
Expert Review of Gastroenterology & Hepatology|July 5, 2017
Sofosbuvir, velpatasvir and voxilaprevir combination for the treatment of hepatitis CRebecca Voaklander, Ira M Jacobson
Journal of the American Academy of Nurse Practitioners|July 28, 2011
Role of the nurse practitioner in the management of patients with chronic hepatitis CMary Olson, Ira M Jacobson
Pageof 19